首页> 外文期刊>Computer Engineering and Intelligent Systems >Computer Aided Drug Design: The Most Fundamental Goal is to Predict Whether a Given Molecule will Bind to a Target and if so How Strongly
【24h】

Computer Aided Drug Design: The Most Fundamental Goal is to Predict Whether a Given Molecule will Bind to a Target and if so How Strongly

机译:计算机辅助药物设计:最基本的目标是预测给定的分子是否会与目标结合,如果结合的话,结合强度如何

获取原文
           

摘要

In the most basic sense, drug design involves the design of small molecules that are complementary in shape and charge to the bimolecular target with which they interact and therefore will bind to it. Drug design, sometimes referred to as?rational drug design?or more simply rational design is the inventive?process of finding new medications based on the knowledge of a biological target. The drug is most commonly an organic small molecule?that activates or inhibits the function of a biomolecule?such as a protein,?which in turn results in a therapeutic benefit to the patient. Drug design frequently but not necessarily relies on computer modeling techniques.?This type of modeling is often referred to as?computer-aided drug design. Finally, drug design that relies on the knowledge of the three-dimensional structure of the bimolecular target is known as structure-based drug design. Structure-based drug design (or?direct drug design) relies on knowledge of the three dimensional structure?of the biological target obtained through methods such as x-ray crystallography or NMR spectroscopy. If an experimental structure of a target is not available, it may be possible to create a homology?of the target based on the experimental structure of a related protein. Using the structure of the biological target, candidate drugs that are predicted to bind with high affinity and selectivity?to the target may be designed using interactive graphics and the intuition of a medicinal chemist. Alternatively various automated computational procedures may be used to suggest new drug candidates.
机译:从最基本的意义上讲,药物设计涉及小分子的设计,这些小分子的形状和电荷与它们相互作用的双分子靶标互补,因此会与其结合。药物设计(有时被称为“理性药物设计”或更简单的理性设计)是根据生物学目标的知识寻找新药物的创造性过程。该药物最常见的是激活或抑制生物分子(例如蛋白质)功能的有机小分子,从而对患者产生治疗益处。药物设计经常但不一定依赖于计算机建模技术。这种类型的建模通常称为“计算机辅助药物设计”。最后,依赖于双分子靶标的三维结构知识的药物设计被称为基于结构的药物设计。基于结构的药物设计(或“直接药物设计”)依赖于通过诸如X射线晶体学或NMR光谱学等方法获得的生物靶标的三维结构知识。如果靶标的实验结构不可用,则可以根据相关蛋白质的实验结构创建靶标的同源性。利用生物靶标的结构,可以使用交互式图形和药物化学家的直觉设计预测与靶标具有高亲和力和选择性结合的候选药物。或者,可以使用各种自动计算程序来建议新的候选药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号